Pharmacovigilance Europe 2015    23rd and 24th June 2015 Key themes:Explore the impact of PV legislation changes and updates on industries and the best practicesAssuring Compliance and its monitoringPreparing for PV audit and inspections and the role of QPPVRisk management plans, strategies and new risk- benefit analysis tools to improve REMS reportingImplementing risk management and safety surveillance methodologies for medical devicesNew approaches for risk minimization and communicationDetermining steps and strategies for more transparency and involvement of patientsDiscussing the how IT and Social media effect Pharmacovigilance and Adverse events reportingDiscuss and review the use of databases and emerging tools for generation and detection of safety signalsImportance of outsourcing and its effectivenessHarmonization of regulatory framework- developed and emerging marketsKey Speakers:Heike Schoepper, Head Global Drug Safety Regions, Merck Serono, a division of MerckKathy Williams, Lead Pharmacovigilance & Regulatory Excellence, GRAPSQA, AstraZenecaPhillip Eichorn, Senior Director (Worldwide Safety and Regulatory), PfizerJacquelyn Awigena-Cook, Associate Director, Head of Pharmacovigilance Policy, Johnson & JohnsonWillemijn van der Spuij, Director of International Operations & Pharmacovigilance Intelligence, Bristol-Myers SquibbSiegfried Schmitt, Principal Consultant, PAREXEL ConsultingSaad Shakir, Director, Drug Safety Research UnitXavier Luria, Chair and Senior Consultant, Drug Development and RegulationPipasha Biswas, Director & QPPV, Pharmacovigilance & Pharmacoepidemiology, SymogenSumit Munjal, Global Director, Pharmacovigilance & EU Region Medical Advisor - Lead Oncology Portfolio, Takeda PharmaceuticalsRachel Spokes, Director Project Management, Pharmacovigilance, Emas PharmaJackie Roberts, Director of Regulatory, Pharmacovigilance and Medical, ActavisGraeme Ladds, Director, PharSaferSeema Jaitly, Managing Director, Essjay SolutionsSandy Eisen, Chief Medical Officer, Frontline Pharma ConsultingVeronique Basch, Executive Director, Global Pharmacovigilance at UBCPlus Many More...Discounts & offers:Introductory Offer - 3 delegate places for the price of 2 - (Limited seats left)Super Early Bird Discount - 16th February 2015 - 31st March 2015 - Conference Delegate Pass (£ 550 + VAT per delegate)Early Bird Discount - 1st April 2015 - 15th May 2015 - Conference Delegate Pass (£ 700 + VAT per delegate)Standard Registration - From 16th May 2015 - Conference Delegate Pass (£ 998  + VAT per delegate)Conference Sponsor & Exhibition Stall – Should you wish to Sponsor, or purchase an Exhibition Stall (Booth) or a paid Speaker Slot, Please feel free to email your interest and queries to: lucy dot raine at gravitonevents dot com